Monitor NNVC stock price relative to the $1.75 warrant exercise price. If the stock rallies above $1.75, expect selling pressure from Orca Capital as the registered shares become exercisable. The warrants are exercisable six months from issuance (November 2026), so no immediate overhang.
Price Chart
Executive Summary
NanoViricides filed an S-3 registration statement to register 1,333,334 shares of common stock for resale by selling stockholder Orca Capital AG, which are issuable upon exercise of warrants at $1.75 per share. The company will not receive any proceeds from the resale, but could receive up to ~$2.33 million if the warrants are exercised for cash. The warrants are currently out of the money (stock at $1.37 vs. $1.75 exercise price), making near-term exercise unlikely. This filing is a routine step fulfilling registration rights from the May 2026 direct offering and does not change the company's precarious financial position (going concern, no revenue).
Key Facts
- Registers 1,333,334 shares of common stock underlying warrants for resale by Orca Capital AG
- Warrants have an exercise price of $1.75 per share, expiring three years from issuance (May 2029)
- Company will receive up to ~$2.33 million in gross proceeds if all warrants are exercised for cash
- Stock price on June 11, 2026 was $1.37, below the $1.75 exercise price
- Company's auditor included a going concern qualification in the most recent 10-K
- Company is a clinical-stage biotech with no revenue or products
Financial Impact
No immediate financial impact. Potential $2.33 million cash inflow if warrants are exercised, but warrants are out of the money at current stock price.
Risk Factors
- Dilution if warrants are exercised (5.8% of current shares outstanding)
- Selling pressure from Orca Capital if stock price exceeds $1.75
- Company's going concern status and need for additional capital
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001104659-26-074065 |
| Document: tm2617201d1_ex-filingfees.htm | 0001104659-26-074065 |
| Document: tm2617201d1_ex5-1.htm | 0001104659-26-074065 |
| Document: tm2617201d1_ex23-2.htm | 0001104659-26-074065 |
| Document: 0001104659-26-074065-index-headers.html | 0001104659-26-074065 |
| Document: 0001104659-26-074065-index.html | 0001104659-26-074065 |
| Document: 0001104659-26-074065.txt | 0001104659-26-074065 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 424B5 | $1.51 | awaiting T+60 | — | $1.36 (−9.93%) |
Oct 8, 2026 18d ago | DEF 14A | $1.31 | awaiting T+60 | — | $1.36 (+3.82%) |
Jul 27, 2026 13w ago | 424B5 | $1.54 $1.48 | ▲ +3.90% | ▲ +7.95% | $1.36 (+11.69%) |
Jul 27, 2026 13w ago | 424B5 | $1.54 $1.48 | ▼ −3.90% | ▼ −7.95% | $1.36 (−11.69%) |
Jun 29, 2026 17w ago | EFFECT | $1.37 $1.51 | ▼ −10.22% | ▼ −6.60% | $1.36 (+0.73%) |
Jun 16, 2026 19w ago | EFFECT | $1.36 $1.02 | ▼ −25.00% | ▼ −26.86% | $1.36 (+0.00%) |
Jun 15, 2026 19w ago | S-3 | $1.36 $1.02 | ▼ −25.00% | ▼ −26.86% | $1.36 (+0.00%) |
Jun 5, 2026 20w ago | S-3 | $1.43 $1.17 | ▲ +18.18% | ▲ +21.69% | $1.36 (+4.90%) |
May 18, 2026 23w ago | 424B5 | $1.51 $1.37 | ▲ +9.27% | ▲ +14.12% | $1.36 (+9.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers